| Canis lupus familiaris |
MDCK |
CC50 |
80000.0 |
nM |
10.1021/ml500236n |
| Electrophorus electricus |
Acetylcholinesterase |
Inhibition |
2.17 |
% |
10.1016/j.bmc.2012.09.040 |
| Equus caballus |
Cholinesterase |
Inhibition |
-3.85 |
% |
10.1016/j.bmc.2012.09.040 |
| Homo sapiens |
786-0 |
GI50 |
100000.0 |
nM |
None |
| Homo sapiens |
A549 |
GI50 |
100000.0 |
nM |
None |
| Homo sapiens |
Acetylcholine receptor; alpha1/beta1/delta/gamma |
EC50 |
11.0 |
nM |
10.1016/j.bmcl.2004.11.073 |
| Homo sapiens |
Acetylcholine receptor; alpha1/beta1/delta/gamma |
Efficacy |
55.0 |
% |
10.1016/j.bmcl.2004.11.073 |
| Homo sapiens |
Acetylcholine receptor; alpha1/beta1/delta/gamma |
Ki |
250.0 |
nM |
10.1016/j.bmcl.2005.08.035 |
| Homo sapiens |
Acetylcholine receptor; alpha1/beta1/delta/gamma |
Ki |
nan |
None |
10.1021/np3007028 |
| Homo sapiens |
ACHN |
GI50 |
100000.0 |
nM |
None |
| Homo sapiens |
Beta-glucocerebrosidase |
Potency |
17782.8 |
nM |
None |
| Homo sapiens |
BT-549 |
GI50 |
100000.0 |
nM |
None |
| Homo sapiens |
CAKI-1 |
GI50 |
100000.0 |
nM |
None |
| Homo sapiens |
CCRF-CEM |
GI50 |
100000.0 |
nM |
None |
| Homo sapiens |
COLO 205 |
GI50 |
100000.0 |
nM |
None |
| Homo sapiens |
Cytochrome P450 1A2 |
AC50 |
31622.78 |
nM |
None |
| Homo sapiens |
Cytochrome P450 1A2 |
AC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2C19 |
AC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2C9 |
AC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2D6 |
AC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 3A4 |
AC50 |
31622.78 |
nM |
None |
| Homo sapiens |
Cytochrome P450 3A4 |
AC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 3A4 |
Potency |
31622.8 |
nM |
None |
| Homo sapiens |
DU-145 |
GI50 |
100000.0 |
nM |
None |
| Homo sapiens |
EKVX |
GI50 |
100000.0 |
nM |
None |
| Homo sapiens |
Fibroblast |
Growth Rate |
-0.82 |
None |
10.6019/CHEMBL5303304 |
| Homo sapiens |
Fibroblast |
Growth Rate |
-0.4 |
None |
10.6019/CHEMBL5303304 |
| Homo sapiens |
Fibroblast |
Growth Rate |
0.51 |
None |
10.6019/CHEMBL5303304 |
| Homo sapiens |
Fibroblast |
Growth Rate |
0.81 |
None |
10.6019/CHEMBL5303304 |
| Homo sapiens |
Fibroblast |
Growth Rate |
0.88 |
None |
10.6019/CHEMBL5303304 |
| Homo sapiens |
Fibroblast |
Growth Rate |
0.99 |
None |
10.6019/CHEMBL5303304 |
| Homo sapiens |
HCC 2998 |
GI50 |
100000.0 |
nM |
None |
| Homo sapiens |
HCT-116 |
GI50 |
100000.0 |
nM |
None |
| Homo sapiens |
HCT-15 |
GI50 |
100000.0 |
nM |
None |
| Homo sapiens |
HEK-293T |
Growth Rate |
0.46 |
None |
10.6019/CHEMBL5303304 |
| Homo sapiens |
HEK-293T |
Growth Rate |
0.75 |
None |
10.6019/CHEMBL5303304 |
| Homo sapiens |
HEK-293T |
Growth Rate |
0.79 |
None |
10.6019/CHEMBL5303304 |
| Homo sapiens |
HEK-293T |
Growth Rate |
0.88 |
None |
10.6019/CHEMBL5303304 |
| Homo sapiens |
HEK-293T |
Growth Rate |
0.9 |
None |
10.6019/CHEMBL5303304 |
| Homo sapiens |
HEK-293T |
Growth Rate |
0.92 |
None |
10.6019/CHEMBL5303304 |
| Homo sapiens |
HEK-293T |
Growth Rate |
0.99 |
None |
10.6019/CHEMBL5303304 |
| Homo sapiens |
Histone deacetylase 6 |
Inhibition |
-0.44 |
% |
10.6019/CHEMBL4808148 |
| Homo sapiens |
Histone deacetylase 6 |
Inhibition |
5.47 |
% |
10.6019/CHEMBL4808148 |
| Homo sapiens |
HOP-62 |
GI50 |
100000.0 |
nM |
None |
| Homo sapiens |
HOP-92 |
GI50 |
100000.0 |
nM |
None |
| Homo sapiens |
Hs-578T |
GI50 |
100000.0 |
nM |
None |
| Homo sapiens |
HT-29 |
GI50 |
100000.0 |
nM |
None |
| Homo sapiens |
IGROV-1 |
GI50 |
100000.0 |
nM |
None |
| Homo sapiens |
K562 |
GI50 |
100000.0 |
nM |
None |
| Homo sapiens |
KM12 |
GI50 |
100000.0 |
nM |
None |
| Homo sapiens |
LOX IMVI |
GI50 |
100000.0 |
nM |
None |
| Homo sapiens |
Lysine-specific demethylase 4D-like |
Potency |
14125.4 |
nM |
None |
| Homo sapiens |
Lysine-specific demethylase 4D-like |
Potency |
22387.2 |
nM |
None |
| Homo sapiens |
M14 |
GI50 |
100000.0 |
nM |
None |
| Homo sapiens |
Malme-3M |
GI50 |
100000.0 |
nM |
None |
| Homo sapiens |
MCF7 |
GI50 |
100000.0 |
nM |
None |
| Homo sapiens |
MDA-MB-231 |
GI50 |
100000.0 |
nM |
None |
| Homo sapiens |
MDA-MB-435 |
GI50 |
100000.0 |
nM |
None |
| Homo sapiens |
MDA-N |
GI50 |
100000.0 |
nM |
None |
| Homo sapiens |
Menin/Histone-lysine N-methyltransferase MLL |
Potency |
39810.7 |
nM |
None |
| Homo sapiens |
Microtubule-associated protein tau |
Potency |
44668.4 |
nM |
None |
| Homo sapiens |
MOLT-4 |
GI50 |
100000.0 |
nM |
None |
| Homo sapiens |
NCI/ADR-RES |
GI50 |
100000.0 |
nM |
None |
| Homo sapiens |
NCI-H23 |
GI50 |
100000.0 |
nM |
None |
| Homo sapiens |
NCI-H322M |
GI50 |
100000.0 |
nM |
None |
| Homo sapiens |
NCI-H460 |
GI50 |
100000.0 |
nM |
None |
| Homo sapiens |
NCI-H522 |
GI50 |
100000.0 |
nM |
None |
| Homo sapiens |
Neuronal acetylcholine receptor; alpha2/beta4 |
Rmax |
58.0 |
% |
10.1021/jm040219e |
| Homo sapiens |
Neuronal acetylcholine receptor; alpha3/beta2 |
EC50 |
67000.0 |
nM |
10.1021/jm040219e |
| Homo sapiens |
Neuronal acetylcholine receptor; alpha3/beta2 |
Rmax |
23.0 |
uM |
10.1021/jm040219e |
| Homo sapiens |
Neuronal acetylcholine receptor; alpha3/beta2 |
Rmax |
55.0 |
% |
10.1021/jm040219e |
| Homo sapiens |
Neuronal acetylcholine receptor; alpha3/beta4 |
EC50 |
26000.0 |
nM |
10.1021/jm970377o |
| Homo sapiens |
Neuronal acetylcholine receptor; alpha3/beta4 |
Ki |
280.0 |
nM |
10.1021/np3007028 |
| Homo sapiens |
Neuronal acetylcholine receptor; alpha3/beta4 |
Ki |
480.0 |
nM |
10.1021/jm401937a |
| Homo sapiens |
Neuronal acetylcholine receptor; alpha3/beta4 |
Ki |
525.0 |
nM |
10.1016/j.bmcl.2006.08.049 |
| Homo sapiens |
Neuronal acetylcholine receptor; alpha3/beta4 |
Ki |
840.0 |
nM |
10.1016/j.bmcl.2005.04.036 |
| Homo sapiens |
Neuronal acetylcholine receptor; alpha3/beta4 |
Ki |
840.0 |
nM |
10.1016/j.bmcl.2005.08.035 |
| Homo sapiens |
Neuronal acetylcholine receptor; alpha3/beta4 |
Ki |
840.0 |
nM |
10.1021/jm050069n |
| Homo sapiens |
Neuronal acetylcholine receptor; alpha3/beta4 |
Ki |
1560.0 |
nM |
10.1016/j.bmcl.2008.02.078 |
| Homo sapiens |
Neuronal acetylcholine receptor; alpha3/beta4 |
Rmax |
56.0 |
% |
10.1021/jm040219e |
| Homo sapiens |
Neuronal acetylcholine receptor; alpha3/beta4 |
Rmax |
77.0 |
% |
10.1021/jm040219e |
| Homo sapiens |
Neuronal acetylcholine receptor; alpha3/beta4 |
Rmax |
89.0 |
% |
10.1021/jm040219e |
| Homo sapiens |
Neuronal acetylcholine receptor; alpha4/beta2 |
EC50 |
0.42 |
nM |
10.1016/j.bmcl.2004.11.073 |
| Homo sapiens |
Neuronal acetylcholine receptor; alpha4/beta2 |
EC50 |
2000.0 |
nM |
10.1021/jm401937a |
| Homo sapiens |
Neuronal acetylcholine receptor; alpha4/beta2 |
EC50 |
38000.0 |
nM |
10.1021/jm970377o |
| Homo sapiens |
Neuronal acetylcholine receptor; alpha4/beta2 |
Efficacy |
6.5 |
% |
10.1021/jm401937a |
| Homo sapiens |
Neuronal acetylcholine receptor; alpha4/beta2 |
Efficacy |
56.0 |
% |
10.1016/j.bmcl.2005.08.035 |
| Homo sapiens |
Neuronal acetylcholine receptor; alpha4/beta2 |
Efficacy |
59.0 |
% |
10.1016/j.bmcl.2004.11.073 |
| Homo sapiens |
Neuronal acetylcholine receptor; alpha4/beta2 |
IC50 |
50.0 |
nM |
10.1021/jm401937a |
| Homo sapiens |
Neuronal acetylcholine receptor; alpha4/beta2 |
IC50 |
28000.0 |
nM |
10.1021/jm401937a |
| Homo sapiens |
Neuronal acetylcholine receptor; alpha4/beta2 |
Inhibition |
30.0 |
% |
10.1016/j.bmcl.2005.04.036 |
| Homo sapiens |
Neuronal acetylcholine receptor; alpha4/beta2 |
Inhibition |
30.0 |
% |
10.1016/j.bmcl.2005.08.035 |
| Homo sapiens |
Neuronal acetylcholine receptor; alpha4/beta2 |
Inhibition |
30.0 |
% |
10.1021/jm050069n |
| Homo sapiens |
Neuronal acetylcholine receptor; alpha4/beta2 |
Ki |
0.23 |
nM |
10.1016/j.bmcl.2005.04.036 |
| Homo sapiens |
Neuronal acetylcholine receptor; alpha4/beta2 |
Ki |
0.23 |
nM |
10.1016/j.bmcl.2005.08.035 |
| Homo sapiens |
Neuronal acetylcholine receptor; alpha4/beta2 |
Ki |
0.28 |
nM |
10.1016/j.bmc.2020.115820 |
| Homo sapiens |
Neuronal acetylcholine receptor; alpha4/beta2 |
Ki |
2.0 |
nM |
10.1021/jm401937a |
| Homo sapiens |
Neuronal acetylcholine receptor; alpha4/beta2 |
Ki |
2.59 |
nM |
10.1016/j.bmcl.2006.08.049 |
| Homo sapiens |
Neuronal acetylcholine receptor; alpha4/beta2 |
Response |
56.0 |
% |
10.1016/j.bmcl.2005.04.036 |
| Homo sapiens |
Neuronal acetylcholine receptor; alpha4/beta2 |
Response |
56.0 |
% |
10.1021/jm050069n |
| Homo sapiens |
Neuronal acetylcholine receptor; alpha4/beta2 |
Rmax |
2.0 |
% |
10.1021/jm040219e |
| Homo sapiens |
Neuronal acetylcholine receptor; alpha4/beta2 |
Rmax |
11.0 |
% |
10.1021/jm040219e |
| Homo sapiens |
Neuronal acetylcholine receptor; alpha4/beta2 |
Rmax |
42.0 |
% |
10.1021/jm040219e |
| Homo sapiens |
Neuronal acetylcholine receptor; alpha4/beta4 |
Rmax |
51.0 |
% |
10.1021/jm040219e |
| Homo sapiens |
Neuronal acetylcholine receptor; alpha4/beta4 |
Rmax |
70.0 |
% |
10.1021/jm040219e |
| Homo sapiens |
Neuronal acetylcholine receptor; alpha4/beta4 |
Rmax |
90.0 |
% |
10.1021/jm040219e |
| Homo sapiens |
Neuronal acetylcholine receptor protein alpha-7 subunit |
EC50 |
71000.0 |
nM |
10.1021/jm040219e |
| Homo sapiens |
Neuronal acetylcholine receptor protein alpha-7 subunit |
EC50 |
71000.0 |
nM |
10.1021/jm970377o |
| Homo sapiens |
Neuronal acetylcholine receptor protein alpha-7 subunit |
Ki |
1420.0 |
nM |
10.1016/j.bmcl.2005.08.035 |
| Homo sapiens |
Neuronal acetylcholine receptor protein alpha-7 subunit |
Ki |
4200.0 |
nM |
10.1016/j.bmcl.2005.04.036 |
| Homo sapiens |
Neuronal acetylcholine receptor protein alpha-7 subunit |
Ki |
5890.0 |
nM |
10.1021/jm401937a |
| Homo sapiens |
OVCAR-3 |
GI50 |
100000.0 |
nM |
None |
| Homo sapiens |
OVCAR-4 |
GI50 |
100000.0 |
nM |
None |
| Homo sapiens |
OVCAR-5 |
GI50 |
100000.0 |
nM |
None |
| Homo sapiens |
OVCAR-8 |
GI50 |
100000.0 |
nM |
None |
| Homo sapiens |
PC-3 |
GI50 |
100000.0 |
nM |
None |
| Homo sapiens |
Prelamin-A/C |
Potency |
63.1 |
nM |
None |
| Homo sapiens |
RXF 393 |
GI50 |
100000.0 |
nM |
None |
| Homo sapiens |
SF-268 |
GI50 |
100000.0 |
nM |
None |
| Homo sapiens |
SF-295 |
GI50 |
100000.0 |
nM |
None |
| Homo sapiens |
SK-MEL-2 |
GI50 |
100000.0 |
nM |
None |
| Homo sapiens |
SK-MEL-28 |
GI50 |
100000.0 |
nM |
None |
| Homo sapiens |
SK-MEL-5 |
GI50 |
100000.0 |
nM |
None |
| Homo sapiens |
SK-OV-3 |
GI50 |
100000.0 |
nM |
None |
| Homo sapiens |
SN12C |
GI50 |
100000.0 |
nM |
None |
| Homo sapiens |
SNB-19 |
GI50 |
100000.0 |
nM |
None |
| Homo sapiens |
SNB-75 |
GI50 |
100000.0 |
nM |
None |
| Homo sapiens |
Solute carrier organic anion transporter family member 1B1 |
Inhibition |
99.71 |
% |
10.1124/mol.112.084152 |
| Homo sapiens |
Solute carrier organic anion transporter family member 1B3 |
Inhibition |
106.19 |
% |
10.1124/mol.112.084152 |
| Homo sapiens |
SW-620 |
GI50 |
100000.0 |
nM |
None |
| Homo sapiens |
T47D |
GI50 |
100000.0 |
nM |
None |
| Homo sapiens |
TK-10 |
GI50 |
100000.0 |
nM |
None |
| Homo sapiens |
U-251 |
GI50 |
100000.0 |
nM |
None |
| Homo sapiens |
U2OS |
Growth Rate |
0.79 |
None |
10.6019/CHEMBL5303304 |
| Homo sapiens |
U2OS |
Growth Rate |
0.94 |
None |
10.6019/CHEMBL5303304 |
| Homo sapiens |
U2OS |
Growth Rate |
0.97 |
None |
10.6019/CHEMBL5303304 |
| Homo sapiens |
U2OS |
Growth Rate |
0.99 |
None |
10.6019/CHEMBL5303304 |
| Homo sapiens |
UACC-257 |
GI50 |
100000.0 |
nM |
None |
| Homo sapiens |
UACC-62 |
GI50 |
100000.0 |
nM |
None |
| Homo sapiens |
Ubiquitin carboxyl-terminal hydrolase 1 |
Potency |
39810.7 |
nM |
None |
| Homo sapiens |
Ubiquitin carboxyl-terminal hydrolase 1 |
Potency |
158489.3 |
nM |
None |
| Homo sapiens |
UO-31 |
GI50 |
100000.0 |
nM |
None |
| Influenza A virus |
Influenza A virus |
EC50 |
80000.0 |
nM |
10.1021/ml500236n |
| Musca domestica |
Nicotinic acetylcholine receptor alpha 5 subunit |
Ki |
1230.0 |
nM |
10.1584/jpestics.17.4_231 |
| Mus musculus |
Mus musculus |
LD50 |
1.73 |
mg.kg-1 |
10.1021/acs.jnatprod.8b00062 |
| Rattus norvegicus |
Inositol monophosphatase 1 |
Potency |
3162.3 |
nM |
None |
| Rattus norvegicus |
Neuronal acetylcholine receptor |
EC50 |
10000.0 |
nM |
10.1021/jm970377o |
| Rattus norvegicus |
Neuronal acetylcholine receptor |
Ki |
2.5 |
nM |
10.1016/j.bmcl.2003.09.105 |
| Rattus norvegicus |
Neuronal acetylcholine receptor; alpha2/beta2 |
Ki |
1.07 |
nM |
10.1021/jm051196m |
| Rattus norvegicus |
Neuronal acetylcholine receptor; alpha2/beta2 |
Ki |
1.4 |
nM |
10.1016/j.bmcl.2003.09.105 |
| Rattus norvegicus |
Neuronal acetylcholine receptor; alpha2/beta4 |
Ki |
5.41 |
nM |
10.1021/jm051196m |
| Rattus norvegicus |
Neuronal acetylcholine receptor; alpha3/beta2 |
Ki |
37.0 |
nM |
10.1016/j.bmcl.2003.09.105 |
| Rattus norvegicus |
Neuronal acetylcholine receptor; alpha3/beta2 |
Ki |
37.2 |
nM |
10.1021/jm051196m |
| Rattus norvegicus |
Neuronal acetylcholine receptor; alpha3/beta4 |
Affinity |
220.0 |
nM |
10.1016/j.bmcl.2004.11.073 |
| Rattus norvegicus |
Neuronal acetylcholine receptor; alpha3/beta4 |
EC50 |
25.0 |
nM |
10.1016/j.bmcl.2004.11.073 |
| Rattus norvegicus |
Neuronal acetylcholine receptor; alpha3/beta4 |
Efficacy |
62.0 |
% |
10.1016/j.bmcl.2004.11.073 |
| Rattus norvegicus |
Neuronal acetylcholine receptor; alpha3/beta4 |
Ki |
203.0 |
nM |
10.1021/jm1006148 |
| Rattus norvegicus |
Neuronal acetylcholine receptor; alpha3/beta4 |
Ki |
210.0 |
nM |
10.1016/j.bmcl.2003.09.105 |
| Rattus norvegicus |
Neuronal acetylcholine receptor; alpha3/beta4 |
Ki |
217.0 |
nM |
10.1021/jm051196m |
| Rattus norvegicus |
Neuronal acetylcholine receptor; alpha4/beta2 |
Affinity |
0.124 |
nM |
10.1016/j.bmcl.2004.11.073 |
| Rattus norvegicus |
Neuronal acetylcholine receptor; alpha4/beta2 |
EC50 |
8.8 |
nM |
10.1021/jm0103561 |
| Rattus norvegicus |
Neuronal acetylcholine receptor; alpha4/beta2 |
EC50 |
nan |
nM |
10.1021/jm970377o |
| Rattus norvegicus |
Neuronal acetylcholine receptor; alpha4/beta2 |
IC50 |
69.18 |
nM |
10.1016/j.bmcl.2010.04.092 |
| Rattus norvegicus |
Neuronal acetylcholine receptor; alpha4/beta2 |
Ki |
0.122 |
nM |
10.1016/j.bmc.2013.09.059 |
| Rattus norvegicus |
Neuronal acetylcholine receptor; alpha4/beta2 |
Ki |
0.122 |
nM |
10.1016/j.bmc.2013.09.060 |
| Rattus norvegicus |
Neuronal acetylcholine receptor; alpha4/beta2 |
Ki |
0.123 |
nM |
10.1021/jm020859m |
| Rattus norvegicus |
Neuronal acetylcholine receptor; alpha4/beta2 |
Ki |
0.17 |
nM |
10.1016/j.bmcl.2005.04.036 |
| Rattus norvegicus |
Neuronal acetylcholine receptor; alpha4/beta2 |
Ki |
0.17 |
nM |
10.1021/jm050069n |
| Rattus norvegicus |
Neuronal acetylcholine receptor; alpha4/beta2 |
Ki |
0.34 |
nM |
10.1021/jm900225j |
| Rattus norvegicus |
Neuronal acetylcholine receptor; alpha4/beta2 |
Ki |
0.4 |
nM |
10.1016/j.bmc.2010.04.065 |
| Rattus norvegicus |
Neuronal acetylcholine receptor; alpha4/beta2 |
Ki |
0.4 |
nM |
10.1016/j.bmc.2020.115820 |
| Rattus norvegicus |
Neuronal acetylcholine receptor; alpha4/beta2 |
Ki |
0.43 |
nM |
10.1016/j.bmcl.2008.02.078 |
| Rattus norvegicus |
Neuronal acetylcholine receptor; alpha4/beta2 |
Ki |
0.48 |
nM |
10.1021/jm900225j |
| Rattus norvegicus |
Neuronal acetylcholine receptor; alpha4/beta2 |
Ki |
1.0 |
nM |
10.1021/jm3011299 |
| Rattus norvegicus |
Neuronal acetylcholine receptor; alpha4/beta2 |
Ki |
1.06 |
nM |
10.1016/j.bmcl.2010.09.017 |
| Rattus norvegicus |
Neuronal acetylcholine receptor; alpha4/beta2 |
Ki |
1.5 |
nM |
10.1016/j.bmcl.2003.09.105 |
| Rattus norvegicus |
Neuronal acetylcholine receptor; alpha4/beta2 |
Ki |
1.51 |
nM |
10.1021/jm051196m |
| Rattus norvegicus |
Neuronal acetylcholine receptor; alpha4/beta2 |
Ki |
1.53 |
nM |
10.1021/jm1006148 |
| Rattus norvegicus |
Neuronal acetylcholine receptor; alpha4/beta2 |
Ki |
1.92 |
nM |
10.1021/jm051196m |
| Rattus norvegicus |
Neuronal acetylcholine receptor; alpha4/beta2 |
Ki |
2.1 |
nM |
10.1021/np3007028 |
| Rattus norvegicus |
Neuronal acetylcholine receptor; alpha4/beta2 |
Ki |
2.78 |
nM |
10.1021/jm010129z |
| Rattus norvegicus |
Neuronal acetylcholine receptor; alpha4/beta2 |
Ki |
4.2 |
nM |
10.1021/jm0103561 |
| Rattus norvegicus |
Neuronal acetylcholine receptor; alpha4/beta4 |
Ki |
2.1 |
nM |
10.1021/jm051196m |
| Rattus norvegicus |
Neuronal acetylcholine receptor; alpha4/beta4 |
Ki |
2.2 |
nM |
10.1016/j.bmcl.2003.09.105 |
| Rattus norvegicus |
Neuronal acetylcholine receptor protein alpha-7 subunit |
Ki |
0.9 |
nM |
10.1021/jm010129z |
| Rattus norvegicus |
Neuronal acetylcholine receptor protein alpha-7 subunit |
Ki |
230.0 |
nM |
10.1021/np3007028 |
| Rattus norvegicus |
Neuronal acetylcholine receptor protein alpha-7 subunit |
Ki |
250.0 |
nM |
10.1016/j.bmc.2013.09.059 |
| Rattus norvegicus |
Neuronal acetylcholine receptor protein alpha-7 subunit |
Ki |
261.0 |
nM |
10.1016/j.bmc.2013.09.060 |
| Rattus norvegicus |
Neuronal acetylcholine receptor protein alpha-7 subunit |
Ki |
300.0 |
nM |
10.1016/j.bmc.2010.04.065 |
| Rattus norvegicus |
Neuronal acetylcholine receptor protein alpha-7 subunit |
Ki |
331.0 |
nM |
10.1021/jm900225j |
| Rattus norvegicus |
Neuronal acetylcholine receptor protein alpha-7 subunit |
Ki |
1000.0 |
nM |
10.1016/j.bmcl.2010.09.017 |
| Rattus norvegicus |
Neuronal acetylcholine receptor protein alpha-7 subunit |
Ki |
1700.0 |
nM |
10.1016/j.bmc.2020.115820 |
| Rattus norvegicus |
Neuronal acetylcholine receptor protein alpha-7 subunit |
Ki |
4200.0 |
nM |
10.1021/jm050069n |
| Rattus norvegicus |
Neuronal acetylcholine receptor protein alpha-7 subunit |
Ki |
5820.0 |
nM |
10.1016/j.bmcl.2008.02.078 |
| Rattus norvegicus |
Neuronal acetylcholine receptor protein alpha-7 subunit |
Ki |
8000.0 |
nM |
10.1021/jm3011299 |
| Rattus norvegicus |
Neuronal acetylcholine receptor protein alpha-7 subunit |
Rmax |
90.0 |
% |
10.1021/jm040219e |
| Rattus norvegicus |
Neuronal acetylcholine receptor protein alpha-7 subunit |
Rmax |
105.0 |
% |
10.1021/jm040219e |
| Rattus norvegicus |
Rattus norvegicus |
Activity |
60.0 |
% |
10.1016/j.bmc.2020.115820 |
| Rattus norvegicus |
Rattus norvegicus |
Biodistribution |
0.2 |
% |
10.1021/jm9910223 |
| Rattus norvegicus |
Rattus norvegicus |
EC50 |
60.0 |
nM |
10.1021/jm970377o |
| Severe acute respiratory syndrome coronavirus 2 |
Replicase polyprotein 1ab |
Inhibition |
-2.316 |
% |
10.6019/CHEMBL4495564 |
| Severe acute respiratory syndrome coronavirus 2 |
Replicase polyprotein 1ab |
Inhibition |
14.59 |
% |
10.6019/CHEMBL4495564 |
| Severe acute respiratory syndrome coronavirus 2 |
Replicase polyprotein 1ab |
Inhibition |
20.97 |
% |
10.6019/CHEMBL4495564 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
IC50 |
19952.62 |
nM |
10.6019/CHEMBL4651402 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
IC50 |
20000.0 |
nM |
10.6019/CHEMBL4651402 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition |
-0.12 |
% |
10.6019/CHEMBL4495565 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition |
-0.04 |
% |
10.6019/CHEMBL4495565 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition |
0.12 |
% |
10.6019/CHEMBL4495565 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition |
5.71 |
% |
10.21203/rs.3.rs-23951/v1 |
| Torpedo californica |
Acetylcholine receptor |
Ki |
250.0 |
nM |
10.1021/jm050069n |
| Torpedo californica |
Acetylcholine receptor protein alpha chain |
Activity |
nan |
None |
10.1584/jpestics.20.49 |
| Torpedo californica |
Acetylcholine receptor protein alpha chain |
IC50 |
3530.0 |
nM |
10.1584/jpestics.20.49 |
| Torpedo californica |
Acetylcholine receptor protein delta chain |
EC50 |
100000.0 |
nM |
10.1021/jm970377o |
| None |
ADMET |
Binding energy |
12.1 |
kCal mol-1 |
10.1021/jm00378a021 |
| None |
Unchecked |
Bmax |
99.1 |
fmol/mg |
10.1016/j.bmc.2020.115820 |
| None |
Unchecked |
EC50 |
900.0 |
nM |
10.1021/jm040219e |
| None |
Unchecked |
EC50 |
2700.0 |
nM |
10.1021/jm040219e |
| None |
Unchecked |
EC50 |
39000.0 |
nM |
10.1021/jm040219e |
| None |
Unchecked |
EC50 |
72000.0 |
nM |
10.1021/jm040219e |
| None |
Unchecked |
IC50 |
140.0 |
nM |
10.1021/np50111a026 |
| None |
Unchecked |
IC50 |
267.0 |
nM |
10.1584/jpestics.20.57 |
| None |
Unchecked |
IC50 |
400000.0 |
nM |
10.1021/np50111a026 |
| None |
Unchecked |
IC50 |
1000000.0 |
nM |
10.1584/jpestics.20.57 |
| None |
Unchecked |
Inhibition |
12.6 |
% |
10.1584/jpestics.20.57 |
| None |
Unchecked |
Kd |
0.145 |
nM |
10.1016/j.bmc.2020.115820 |
| None |
Unchecked |
Ki |
0.16 |
nM |
10.1016/j.bmc.2020.115820 |
| None |
Unchecked |
Ki |
5.5 |
nM |
10.1016/j.bmcl.2003.09.105 |
| None |
Unchecked |
Ki |
18.0 |
nM |
10.1016/j.bmc.2013.09.060 |
| None |
Unchecked |
Ki |
19.0 |
nM |
10.1016/j.bmc.2013.09.059 |
| None |
Unchecked |
Ki |
144.0 |
nM |
10.1021/jm051196m |
| None |
Unchecked |
Ki |
250.0 |
nM |
10.1016/j.bmcl.2005.04.036 |
| None |
Unchecked |
Ki |
650.0 |
nM |
10.1584/jpestics.17.4_231 |
| None |
Unchecked |
Ki |
1300.0 |
nM |
10.1016/j.bmc.2013.09.059 |
| None |
Unchecked |
Ki |
1300.0 |
nM |
10.1016/j.bmc.2013.09.060 |
| None |
Unchecked |
Ki |
400000.0 |
nM |
10.1016/j.bmc.2020.115820 |
| None |
Unchecked |
Potency |
206.0 |
nM |
None |
| None |
Unchecked |
Ratio |
1.0 |
None |
10.1016/j.bmcl.2003.09.105 |
| None |
Unchecked |
Ratio |
4.0 |
None |
10.1016/j.bmcl.2003.09.105 |
| None |
Unchecked |
Ratio |
6.0 |
None |
10.1016/j.bmcl.2003.09.105 |
| None |
Unchecked |
Ratio |
84.0 |
None |
10.1016/j.bmcl.2003.09.105 |
| None |
Unchecked |
Ratio Ki |
203.0 |
None |
10.1016/j.bmcl.2006.08.049 |